LeonaBio (LONA) Shares Outstanding (2019 - 2026)

LeonaBio (LONA) has reported Shares Outstanding (Entity) for 8 consecutive years, with $19.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 387.34% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $19.0 million (up 387.34% YoY), while the FY2025 annual figure was $4.3 million, up 9.52% from the prior year.
• Shares Outstanding (Entity) improved to $19.0 million in Q1 2026 per LONA's latest filing, from $4.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $19.0 million in Q1 2026 and bottomed at $3.8 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $4.8 million across 5 years, with a median of $3.8 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 0.63% — and 2026, when it surged 387.34%.
• LeonaBio's Shares Outstanding (Entity) stood at $3.8 million in 2022, then rose by 0.78% to $3.8 million in 2023, then increased by 2.27% to $3.9 million in 2024, then gained by 9.52% to $4.3 million in 2025, then surged by 345.0% to $19.0 million in 2026.
• Business Quant data shows LONA's Shares Outstanding (Entity) at $19.0 million in Q1 2026, $4.3 million in Q4 2025, and $3.9 million in Q3 2025.